A large number and variety of substances have been measured using dried-blood spots. Click here to see a list (PDF 8KB) obtained from literature citations for an indication of applications for this versatile matrix.
NSQAP has conducted research and provided technical assistance in using dried-blood spots to measure autoantibodies related to type 1 diabetes. NSQAP has conducted two workshops on this topic and recently obtained funding from the National Institutes of Health to develop a pilot program for population-based screening for type 1 diabetes using newborn bloodspots.
NSQAP also applies its bloodspot technology to detect HIV-1 antibodies. NSQAP has provided quality assurance services for surveys of HIV infection and consultation services for other applications of bloodspot technology.
